loading

Cartesian Therapeutics Inc Azioni (RNAC) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
72.91%
0.298
1.10 -0.759 0.387 33.45
Operating Expenses
3.83%
22.11
22.99 25.97 17.96 19.69
Benefits Costs and Expenses
-
- 116.05 - -
Costs And Expenses
3.83%
22.11
22.99 59.21 17.96 19.69
Operating Income/Loss
0.36%
-21.81
-21.89 -26.73 -17.57 13.76
Income/Loss From Continuing Operations Before Tax
101.68%
0.298
-17.71 -116.81 0.387 13.84
Income/Loss From Continuing Operations After Tax
189.70%
15.89
-17.71 -10.25 -24.18 13.84
Net Income/Loss
189.70%
15.89
-17.71 -10.25 -24.18 13.84
Preferred Stock Dividends And Other Adjustments
2.628
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.30%
25.98
25.90 2.7152 21.47 16.72
Diluted Average Shares
2.10%
26.45
25.90 2.7963 21.47 17.79
Basic Earnings Per Share
175.00%
0.51
-0.68 0.13 -1.13 0.58
Diluted Earnings Per Share
173.53%
0.50
-0.68 0.12 -1.13 0.54
Undistributed Earnings/Loss Allocated To Participating Securities, Basic
200.00%
2.628
-2.628 - - 4.208
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
5.256
- - - -
$35.85
price down icon 0.50%
$85.88
price down icon 0.69%
$27.47
price down icon 0.27%
$102.78
price down icon 8.61%
$146.33
price up icon 0.83%
biotechnology ONC
$345.12
price up icon 1.02%
Capitalizzazione:     |  Volume (24 ore):